JP2016516076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016516076A5 JP2016516076A5 JP2016503654A JP2016503654A JP2016516076A5 JP 2016516076 A5 JP2016516076 A5 JP 2016516076A5 JP 2016503654 A JP2016503654 A JP 2016503654A JP 2016503654 A JP2016503654 A JP 2016503654A JP 2016516076 A5 JP2016516076 A5 JP 2016516076A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- insulin
- chain
- long
- cooh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13160194.0 | 2013-03-20 | ||
| EP13160194 | 2013-03-20 | ||
| US201361804363P | 2013-03-22 | 2013-03-22 | |
| US61/804,363 | 2013-03-22 | ||
| PCT/EP2014/055533 WO2014147141A1 (en) | 2013-03-20 | 2014-03-19 | Insulin dosing regimen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016516076A JP2016516076A (ja) | 2016-06-02 |
| JP2016516076A5 true JP2016516076A5 (enExample) | 2017-04-27 |
| JP6755175B2 JP6755175B2 (ja) | 2020-09-16 |
Family
ID=47900938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503654A Expired - Fee Related JP6755175B2 (ja) | 2013-03-20 | 2014-03-19 | インスリン投薬レジメン |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US20160296602A1 (enExample) |
| EP (1) | EP2976096B1 (enExample) |
| JP (1) | JP6755175B2 (enExample) |
| CN (1) | CN105188736A (enExample) |
| WO (1) | WO2014147141A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1969004B1 (en) | 2005-12-28 | 2011-08-10 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
| CN102202683A (zh) | 2008-10-30 | 2011-09-28 | 诺沃-诺迪斯克有限公司 | 用少于每日一次的注射频率注射胰岛素来治疗糖尿病 |
| DK2632478T3 (da) | 2010-10-27 | 2019-10-07 | Novo Nordisk As | Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller |
| EP2991672A1 (en) | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
| EP3544683A1 (en) | 2016-11-28 | 2019-10-02 | Novo Nordisk A/S | Insulin degludec in cardiovascular conditions |
| MA46890A (fr) * | 2016-11-28 | 2021-04-28 | Novo Nordisk As | Insuline degludec pour l'amélioration du contrôle glycémique et la réduction des complications du diabète aigu et à long terme |
| WO2018096164A1 (en) * | 2016-11-28 | 2018-05-31 | Novo Nordisk A/S | Insulin degludec for treating diabetes |
| AU2018216008A1 (en) | 2017-02-01 | 2019-08-01 | Novo Nordisk A/S | Procoagulant antibodies |
| JOP20190273A1 (ar) | 2017-05-26 | 2019-11-24 | Lilly Co Eli | مركب إنسولين معالج بأسيل |
| AR112015A1 (es) | 2017-06-09 | 2019-09-11 | Novo Nordisk As | Composiciones sólidas para administración oral |
| CN112313755B (zh) * | 2018-06-26 | 2024-05-28 | 诺和诺德股份有限公司 | 为基础胰岛素滴定提供剂量推荐的系统 |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| US11220554B2 (en) | 2018-09-07 | 2022-01-11 | Novo Nordisk A/S | Procoagulant antibodies |
| TW202039437A (zh) | 2018-12-11 | 2020-11-01 | 法商賽諾菲公司 | 肽黏合劑 |
| CN114096269B (zh) | 2019-07-12 | 2024-06-11 | 诺和诺德股份有限公司 | 高浓度胰岛素制剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004261353B2 (en) * | 2003-08-05 | 2009-12-10 | Novo Nordisk A/S | Novel insulin derivatives |
| ES2472421T3 (es) * | 2003-08-05 | 2014-07-01 | Novo Nordisk A/S | Nuevos derivados de insulina |
| EP1969004B1 (en) * | 2005-12-28 | 2011-08-10 | Novo Nordisk A/S | Compositions comprising an acylated insulin and zinc and method of making the said compositions |
| CN101454019A (zh) * | 2006-04-12 | 2009-06-10 | 百达尔公司 | 速效和长效胰岛素联合制剂 |
| JP5552046B2 (ja) * | 2007-06-13 | 2014-07-16 | ノボ・ノルデイスク・エー／エス | インスリン誘導体を含有する薬学的製剤 |
| WO2009022006A1 (en) * | 2007-08-15 | 2009-02-19 | Novo Nordisk A/S | Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids |
| CN102202683A (zh) * | 2008-10-30 | 2011-09-28 | 诺沃-诺迪斯克有限公司 | 用少于每日一次的注射频率注射胰岛素来治疗糖尿病 |
| AU2011252127B2 (en) * | 2010-05-10 | 2014-02-20 | Novo Nordisk A/S | Process for the preparation of insulin-zinc complexes |
| AU2011202239C1 (en) * | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
| KR20130139297A (ko) * | 2010-10-27 | 2013-12-20 | 노보 노르디스크 에이/에스 | 다양한 주사 간격으로 투여된 인슐린 주사를 이용한 진성 당뇨병의 치료 |
| AU2012213432B2 (en) * | 2011-02-01 | 2016-10-13 | Novo Nordisk A/S | Purification of insulin |
| AU2012223282B2 (en) * | 2011-03-01 | 2017-02-02 | Nutrition 21, Llc | Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders |
| EP2844274B1 (en) * | 2012-05-01 | 2019-03-20 | Novo Nordisk A/S | Pharmaceutical composition |
| EP2991672A1 (en) * | 2013-04-30 | 2016-03-09 | Novo Nordisk A/S | Novel administration regime |
-
2014
- 2014-03-19 US US14/777,789 patent/US20160296602A1/en not_active Abandoned
- 2014-03-19 CN CN201480016936.1A patent/CN105188736A/zh not_active Withdrawn
- 2014-03-19 WO PCT/EP2014/055533 patent/WO2014147141A1/en not_active Ceased
- 2014-03-19 JP JP2016503654A patent/JP6755175B2/ja not_active Expired - Fee Related
- 2014-03-19 EP EP14713072.8A patent/EP2976096B1/en not_active Not-in-force
-
2017
- 2017-05-22 US US15/601,506 patent/US20170319664A1/en not_active Abandoned
-
2019
- 2019-01-30 US US16/262,383 patent/US20190160155A1/en not_active Abandoned
-
2021
- 2021-12-16 US US17/553,008 patent/US20220152160A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Melson et al. | Future therapies for obesity | |
| DK1965823T3 (en) | Methods of administering hypoglycemics | |
| RU2011117645A (ru) | Лечение сахарного диабета с использованием инъекций инсулина с частотой менее одного раза в день | |
| RU2419452C2 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ hGLP-1, ЭКСЕНДИНА-4 И ИХ АНАЛОГОВ | |
| JP2007523881A5 (enExample) | ||
| US20080213288A1 (en) | Combined Use Of A Modulator Of CD3 And A GLP-1 Compound | |
| RU2012123739A (ru) | Фармацевтическая композиция, содержащая агонист гпп-1 и метионин | |
| JP2014520798A5 (enExample) | ||
| RU2014126244A (ru) | Лекарственные средства, содержащие аминокислотные последовательности инсулина | |
| JP2014501762A5 (enExample) | ||
| RU2013139651A (ru) | Новые соединения, влияющие на пищевое поведение | |
| JP2011241213A5 (enExample) | ||
| JP2011001381A (ja) | Ｇｌｐ−１医薬組成物 | |
| EP2185178A2 (en) | Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity | |
| RU2015132860A (ru) | Композиции инсулинов длительного действия | |
| MX2012006744A (es) | Tiazolidinadionas reguladores de receptores activados por proliferador de peroxisoma (ppar) y combinaciones para el tratamiento de diabetes mellitus y otras enfermedades metabolicas. | |
| Brandt et al. | Are peptide conjugates the golden therapy against obesity? | |
| Edmonds et al. | Oral GLP-1 modulators for the treatment of diabetes | |
| JP2015517458A5 (enExample) | ||
| RU2014147674A (ru) | Фармацевтическая композиция | |
| Woo | A review of the clinical efficacy and safety of insulin degludec and glargine 300 U/mL in the treatment of diabetes mellitus | |
| Lee et al. | Incretin-based therapies through the decades: molecular innovations and clinical impact | |
| JP2014500244A5 (enExample) | ||
| JP6049625B2 (ja) | 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療 | |
| Shibata et al. | Effect of glucagon, glicentin, glucagon-like peptide-1 and-2 on interdigestive gastroduodenal motility in dogs with a vagally denervated gastric pouch |